Institute Of Biomedical Research
(OTC) MRES
Institute Of Biomedical Research Financials at a Glance
Market Cap
$3.57M
Revenue (TTM)
$36.31K
Net Income (TTM)
$213.78K
EPS (TTM)
$-0.00
P/E Ratio
-4.33
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$0.00
Volume
2,340,000
Open
$0.00
Price
$0.00
Volume
2,340,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.02
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$0.00
Volume
2,340,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.02
MRES News
MRES: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Institute Of Biomedical Research
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
5
CEO
Peter Jeffrey Robinson
Website
www.mrescorp.comHeadquarters
Podgorica, 81000, ME
MRES Financials
Key Financial Metrics (TTM)
Gross Margin
38%
Operating Margin
-12%
Net Income Margin
-6%
Return on Equity
-61%
Return on Capital
-18%
Return on Assets
-7%
Earnings Yield
-23.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.57M
Shares Outstanding
2.75B
Volume
2.34M
Short Interest
0.00%
Avg. Volume
810.36K
Financials (TTM)
Gross Profit
$21.40K
Operating Income
$756.51K
EBITDA
$724.26K
Operating Cash Flow
$231.77K
Capital Expenditure
$7.50K
Free Cash Flow
$239.27K
Cash & ST Invst.
$11.80K
Total Debt
$0.00
Institute Of Biomedical Research Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$3.57M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$31.28K
+93.1%
EBITDA
$55.34K
+86.2%
Quarterly Fundamentals
Net Cash
$3.58K
+225.6%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
-100.0%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-6.65%
N/A
Return on Invested Capital
-17.70%
N/A
Free Cash Flow
$5.18K
+94.7%
Operating Cash Flow
$5.18K
+94.7%